VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $90,661,512 | -17.5% | 3,369,064 | -9.2% | 0.09% | -30.6% |
| Q2 2023 | $109,937,503 | +91036.1% | 3,711,597 | +0.1% | 0.13% | -28.3% |
| Q1 2023 | $120,630 | +67.3% | 3,709,416 | +47.4% | 0.19% | +70.0% |
| Q4 2022 | $72,121 | -99.9% | 2,516,448 | +21.3% | 0.11% | +41.0% |
| Q3 2022 | $49,164,000 | +27.3% | 2,075,341 | +52.8% | 0.08% | +21.9% |
| Q2 2022 | $38,626,000 | -49.2% | 1,358,181 | -30.9% | 0.06% | -34.7% |
| Q1 2022 | $75,984,000 | +37.1% | 1,965,935 | +2.5% | 0.10% | +58.1% |
| Q3 2021 | $55,436,000 | -6.0% | 1,917,518 | +9.3% | 0.06% | -32.6% |
| Q2 2021 | $59,002,000 | +44.3% | 1,753,941 | +36.5% | 0.09% | +48.4% |
| Q1 2021 | $40,886,000 | -33.9% | 1,284,533 | -24.0% | 0.06% | -35.4% |
| Q4 2020 | $61,823,000 | -2.5% | 1,691,002 | +5.0% | 0.10% | -37.7% |
| Q3 2020 | $63,417,000 | +36.0% | 1,610,791 | +22.8% | 0.15% | +21.3% |
| Q2 2020 | $46,638,000 | +47.7% | 1,311,532 | -0.6% | 0.13% | +32.3% |
| Q1 2020 | $31,570,000 | -27.6% | 1,319,240 | -10.7% | 0.10% | -9.4% |
| Q4 2019 | $43,588,000 | +12.3% | 1,478,065 | +4.5% | 0.11% | -5.4% |
| Q3 2019 | $38,825,000 | +67.9% | 1,414,380 | +37.1% | 0.11% | +67.2% |
| Q1 2019 | $23,122,000 | +20.0% | 1,031,314 | +10.2% | 0.07% | +21.8% |
| Q4 2018 | $19,273,000 | -57.7% | 935,564 | -62.0% | 0.06% | -45.0% |
| Q3 2018 | $45,548,000 | +162.3% | 2,459,365 | +211.3% | 0.10% | +143.9% |
| Q2 2018 | $17,368,000 | 0.0% | 790,157 | 0.0% | 0.04% | 0.0% |
| Q1 2018 | $17,368,000 | -38.8% | 790,157 | -35.3% | 0.04% | -60.2% |
| Q4 2017 | $28,385,000 | -14.2% | 1,221,362 | -15.2% | 0.10% | -18.3% |
| Q3 2017 | $33,076,000 | -4.8% | 1,440,578 | -9.0% | 0.13% | -21.2% |
| Q2 2017 | $34,746,000 | -24.0% | 1,583,003 | -21.9% | 0.16% | -36.5% |
| Q1 2017 | $45,718,000 | +26.4% | 2,027,390 | +17.2% | 0.25% | +41.6% |
| Q4 2016 | $36,180,000 | -20.7% | 1,729,446 | +1.2% | 0.18% | -16.0% |
| Q3 2016 | $45,598,000 | +7.4% | 1,708,413 | +9.2% | 0.21% | -11.7% |
| Q2 2016 | $42,469,000 | – | 1,564,265 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |